Crystal Structure of Medicinal Product Triazavirin

被引：6
|
作者：
Voinkov, E. K. [1 ]
Drokin, R. A. [1 ]
Ulomskiy, E. N. [1 ,2 ]
Slepukhin, P. A. [2 ]
Rusinov, V. L. [1 ,2 ]
Chupakhin, O. N. [1 ,2 ]
机构：
[1] Ural Fed Univ, Dept Organ & Biomol Chem, 19 Mira St, Ekaterinburg 620002, Russia
[2] RAS, Inst Organ Synth, Ural Div, 22-20 S Kovalevskoy St,Akad Skaya St, Ekaterinburg 620990, Russia
来源：
JOURNAL OF CHEMICAL CRYSTALLOGRAPHY | 2019年 / 49卷 / 04期
基金：
俄罗斯科学基金会;
关键词：
Triazavirin; Antiviral; Triazolotriazine; Drug; Thermogravimetry; PROPHYLACTIC EFFICACY; INFLUENZA-VIRUS; ENCEPHALITIS;
D O I：
10.1007/s10870-018-0750-2
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
The X-ray data of 2-methylsulfanyl-6-nitro-1,2,4-triazolo [5,1-c][1,2,4]triazin-7-one sodium salt dihydrate (triazavirin) is reported. The compound crystallizes in the form binuclear complex ?? triclinic space group P-1 with unit cell parameters: a=7.2616 (6) angstrom, b=9.3036 (5) angstrom, c=9.5237 (7) angstrom, alpha=110.968 (6), beta=92.600 (6)degrees, gamma=102.990 (6)degrees and Z=1. [GRAPHICS] . Graphical AbstractInteraction of 3-(methylsulfanyl)-1H-1,2,4-triazole-5-diazonium hydrochloride with ethyl nitroacetate in sodium carbonate solution resulted in the formation of centrosymmetric binuclear complex of 2-methylsulfanyl-6-nitro-1,2,4-triazolo[5,1-c][1,2,4]triazin-7-one sodium salt dihydrate (triazavirin), which was structurally characterized.
引用
收藏
页码：213 / 218
页数：6
相关论文
共 50 条
  • [1] Crystal Structure of Medicinal Product Triazavirin
    E. K. Voinkov
    R. A. Drokin
    E. N. Ulomskiy
    P. A. Slepukhin
    V. L. Rusinov
    O. N. Chupakhin
    Journal of Chemical Crystallography, 2019, 49 : 213 - 218
  • [2] Validation of the Crystal Structure of Medicinal Realgar in China
    Zhang Zhi-jie
    Zhou Qun
    Wei Jing-zhi
    Zhang Yan-ling
    Sun Su-qin
    Huang Lu-qi
    Yuan Si-tong
    SPECTROSCOPY AND SPECTRAL ANALYSIS, 2011, 31 (02) : 291 - 296
  • [3] The crystal structure of lacidipine phototransformation product
    Simonic, Igor
    Zupancic, Silvo
    Golobic, Amalija
    Golic, Ljubo
    Stanovnik, Branko
    ACTA CHIMICA SLOVENICA, 2008, 55 (02) : 458 - 461
  • [4] THE USE OF CRYSTAL-STRUCTURE DATA IN MEDICINAL CHEMISTRY
    MURRAYRUST, P
    ACTA CRYSTALLOGRAPHICA SECTION A, 1984, 40 : C56 - C56
  • [5] CRYSTAL AND MOLECULAR STRUCTURE OF NATURAL PRODUCT TOXOCAHOL
    Zhang Zeying Zhang MingzheDepartment of Chemistry
    结构化学, 1987, (02) : 128 - 131
  • [6] CRYSTAL AND MOLECULAR STRUCTURE OF A BROMINATION PRODUCT OF (+)TETRAHYDRORUGULOSIN
    KOBAYASHI, N
    IITAKA, Y
    SANKAWA, U
    OGIHARA, Y
    SHIBATA, S
    TETRAHEDRON LETTERS, 1968, (58) : 6135 - +
  • [7] Medicinal product safety and patient safety Challenges of the interface "man-medicinal product"
    Franz, D.
    Roeder, N.
    ZENTRALBLATT FUR CHIRURGIE, 2009, 134 (04): : 277 - 280
  • [8] CRYSTAL-STRUCTURE OF THE PRODUCT OF AN ANOMALOUS ROBINSON ANNULATION
    CARTER, B
    LAING, M
    SOMMERVILLE, P
    SOUTH AFRICAN JOURNAL OF CHEMISTRY, 1984, 37 (02) : 53 - 56
  • [9] Crystal Structure of a Commercial Product Called Lead Cvanurate
    Dolabdjian, Konstantin
    Stroebele, Markus
    Meyer, H. -Juergen
    ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, 2015, 641 (05): : 765 - 768
  • [10] CRYSTAL STRUCTURE OF ADDITION PRODUCT OF A GRIGNARD REAGENT WITH A KETONE
    MOSELEY, PT
    SHEARER, HMM
    CHEMICAL COMMUNICATIONS, 1968, (05) : 279 - &
12345